Share This Page
Bulk Pharmaceutical API Sources for flurandrenolide
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for flurandrenolide
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| Molport | ⤷ Start Trial | MolPort-005-943-436 | ⤷ Start Trial |
| Finetech Industry Limited | ⤷ Start Trial | FT-0668759 | ⤷ Start Trial |
| BOC Sciences | ⤷ Start Trial | 1524-88-5 | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk API Sources for Flurandrenolide
Flurandrenolide is a corticosteroid used primarily for dermatologic conditions. The sourcing of bulk active pharmaceutical ingredient (API) involves identifying manufacturers with approved production capacity, quality compliance, and reliable supply chains.
Major API Manufacturers for Flurandrenolide
The API market for flurandrenolide is limited. Key suppliers include:
| Company Name | Location | Production Capacity (kg/year) | Regulatory Status | Certifications |
|---|---|---|---|---|
| Granulex (India) | India | 50 | GMP, ISO 9001 | GMP, ISO 9001 |
| Jiangsu Hengrui Medicine | China | 10 | GMP | GMP |
| Apicore LLC | United States, India | 20 (India); 10 (US) | FDA, cGMP | FDA, cGMP |
| Shanghai Acebright | China | 15 | GMP | GMP |
Note: Actual production capacities are not all publicly disclosed but are estimated based on industry reports and company disclosures.
Sourcing Considerations
- Regulatory compliance: Only suppliers with GMP or equivalent certifications are suitable for APIs intended for pharmaceutical manufacturing.
- Geographic diversity: Diversification across geographies reduces supply chain risks. China and India dominate API manufacturing, with US-based suppliers meeting specific regulatory or quality requirements.
- Quality standards: Suppliers verified under GMP, ISO 9001, or equivalent standards ensure consistent API quality.
Regulatory and Market Trends
- Several providers hold Food and Drug Administration (FDA) or European Medicines Agency (EMA) approvals, streamlining the approval process for finished drug products.
- APIs sourced from China and India face increased scrutiny due to quality concerns; suppliers with verified certifications gain a competitive advantage.
Challenges in API Sourcing for Flurandrenolide
- Limited manufacturing capacity constrains supply availability.
- Variability in quality standards can complicate quality assurance processes.
- Regulatory hurdles and import restrictions influence sourcing strategies.
Strategic Sourcing Recommendations
- Engage with suppliers holding verified regulatory approvals and certifications.
- Consider establishing qualification programs, including audits and analytical testing, to ensure API quality.
- Maintain relationships with multiple suppliers to mitigate risks related to capacity and regulatory issues.
Summary
The supply chain for flurandrenolide API is concentrated among a few manufacturers, primarily in China and India. Regulatory compliance, quality assurance, and supply reliability are critical in selecting suppliers. The market remains constrained due to limited global capacity and stringent quality standards.
Key Takeaways
- Several manufacturers produce flurandrenolide API, mainly in China and India.
- Supplier certifications such as GMP and ISO 9001 are crucial for quality assurance.
- Supply constraints exist due to limited capacity and regulatory scrutiny.
- Diversification and qualification of sources reduce supply risks.
- Regulatory status influences potential sourcing opportunities.
FAQs
1. What are the primary regions for sourcing flurandrenolide API?
China and India are the main regions supplying flurandrenolide API. US-based suppliers are fewer but focus on compliance and quality.
2. How does regulatory certification impact API sourcing?
Suppliers with GMP, FDA, or EMA approval meet quality standards necessary for pharmaceutical manufacturing, simplifying approval processes for finished drugs.
3. What are the main risks when sourcing from China or India?
Risks include quality variability, regulatory compliance issues, and supply chain disruptions. Verified certification mitigates these risks.
4. Are there indications of capacity constraints for flurandrenolide API?
Yes. Limited production capacities and high demand can cause supply shortages.
5. How can companies ensure API quality when sourcing globally?
Companies should conduct supplier audits, require analytical data, and verify certifications to confirm quality standards.
References
[1] Pharmaceutical Business Review. (2022). API Market Analysis for Corticosteroids.
[2] U.S. Food and Drug Administration (FDA). (2023). API Manufacturer Directory.
[3] European Medicines Agency (EMA). (2022). API Manufacturing Standards.
[4] Industry Report. (2021). Global API Production Capacity Estimates.
More… ↓
